Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH)

$CSRPress releaseSep 9, 2026, 11:43 AM ETRead the release

Brodsky & Smith, a shareholder-rights law firm, is advertising an investigation into whether the Centerspace board breached fiduciary duties in its all-stock merger agreement with Independence Realty Trust. This is a law-firm solicitation, not a disclosure from the company. Under the merger agreement, Centerspace shareholders would receive 3.800 IRT shares per share owned, leaving IRT holders with roughly 78% and Centerspace holders with roughly 22% of the combined company on a fully diluted basis. The same release also touts investigations into pending takeovers of Fulcrum Therapeutics, Weave Communications, and Bio-Techne.

Key figures

Tech per share price
$73.00
Tech enterprise value
$11.3 billion
Weave per share price
$7.40
Csr irt exchange ratio
3.800 IRT shares per CSR share
Weave equity valuation
$650 Million
Csr post close ownership
approximately 22%
Irt post close ownership
approximately 78%
Fulc post close ownership
5.0% of combined company

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    CSR: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH) — AI Analysis | Signal8